Sign in

pituitarysociety.bsky.social

@pituitarysociety.bsky.social
35 followers 22 following 3 posts
PostsRepliesMedia
Reposted by @pituitarysociety.bsky.social
Nature Reviews Endocrinology @natrevendo.nature.com · 14/09/2026
Here, this international Consensus Statement by Maria Fleseriu et al provides guidelines on the management of pituitary incidentalomas go.nature.com/4itSjB3 #EndoSky #MedSky
Figure showing an algorithm for assessment of an incidentally discovered pituitary adenoma on imaging managed conservatively.
001
Reposted by @pituitarysociety.bsky.social
Nature Reviews Endocrinology @natrevendo.nature.com · 27/08/2026
ICYMI: New content online: Genetic testing in pituitary adenomas: a Pituitary Society International Consensus Statement
go.nature.com
Genetic testing in pituitary adenomas: a Pituitary Society International Consensus Statement
Nature Reviews Endocrinology, Published online: 25 August 2026; doi:10.1038/s41574-026-01291-4This Consensus Statement provides evidence-based guidance on the clinical application of genetic tests in pituitary adenomas (focusing on germline genetic testing), with recommendations regarding genes for inclusion in panel testing, test indications, pre-test counselling, test methodologies, and result interpretation and follow-up.
021
Reposted by @pituitarysociety.bsky.social
Nature Reviews Endocrinology @natrevendo.nature.com · 25/08/2026
New content online: Genetic testing in pituitary adenomas: a Pituitary Society International Consensus Statement
go.nature.com
Genetic testing in pituitary adenomas: a Pituitary Society International Consensus Statement
Nature Reviews Endocrinology, Published online: 25 August 2026; doi:10.1038/s41574-026-01291-4This Consensus Statement provides evidence-based guidance on the clinical application of genetic tests in pituitary adenomas (focusing on germline genetic testing), with recommendations regarding genes for inclusion in panel testing, test indications, pre-test counselling, test methodologies, and result interpretation and follow-up.
022
Reposted by @pituitarysociety.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 23/08/2026
In both sexes, #hyperprolactinaemia increases appetite, weight, insulin resistance, and lipid abnormalities. Bone health is compromised due to hypogonadism, prolactin-induced bone resorption, and reduced muscle mass www.thelancet.com/journals/lan... #prolactinomas #prolactin #pituitary #adenomas
Clinical features might be different in children and adolescents, which could drive diagnostic workup and influence treatment decisions. *Common presentation in women, extremely rare for men.
001
Reposted by @pituitarysociety.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 23/08/2026
Most patients [with #acromegaly] have a growth hormone-secreting #pituitary #adenoma & exhibit multiple, often serious, comorbidities as well as impaired quality of life (QoL) at the time of diagnosis because of substantial delays in recognising the disorder www.thelancet.com/journals/lan... #MedSky
(A) Causes of acromegaly due to central (left) and ectopic (right) growth hormone excess. (B) Clinical features and comorbidities common in patients with acromegaly, with further examples in pictures: (a) changes in facial features due to uncontrolled growth hormone excess between early adulthood (left picture) and more than 20 years later, after delayed diagnosis (right picture); (b) CT scan showing prominent supraorbital ridges and pituitary macroadenoma; (c) hand of a patient with acromegaly compared with the hand of a physician; (d) skin tags; and (e) chest x-ray showing enlarged heart.
012
Reposted by @pituitarysociety.bsky.social
Maria Fleseriu, MD @mariafleseriu.bsky.social · 22/08/2026
Just out! Consensus on biomarker utility for ACTH-dependent Cushing syndrome: a Pituitary Society Modified Delphi Panel academic.oup.com/jcem/article...
academic.oup.com
Consensus on biomarker utility for ACTH-dependent Cushing syndrome: a Pituitary Society Modified Delphi Panel
AbstractContext. Biochemical test results are central to clinical decision-making for the diagnosis and management of Cushing syndrome (CS). With emerging
041
pituitarysociety.bsky.social @pituitarysociety.bsky.social · 19/08/2026
Shaping Acromegaly Care: Episode 1, 2 more to come. Join Dr Maria Fleseriu @mariafleseriu.bsky.social @ohsunews.bsky.social & Dr Shlomo Melmed Listen here go.screenpal.com/player/cOjXY... Is intended for US healthcare professionals only #Pituitary #Acromegaly #Endocrinology #MedicalEducation
011
Reposted by @pituitarysociety.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 12/07/2026
Hyperprolactinaemia can also result from #dopamine antagonist drug effects and reduced prolactin clearance with liver or kidney disease with loss of feedback regulation www.thelancet.com/journals/lan... #hyperprolactinaemia #prolactinomas #pituitary #adenomas #MedSky #EndoSky
Colour coding indicates likely effect of each medication on prolactin. Observed prolactin elevations are not consistent in all patients. GnRH=gonadotropin-releasing hormone. H2=histamine 2. MAO=monoamine oxidase. SNRI=serotonin and norepinephrine reuptake inhibitors. SSRI=selective serotonin reuptake inhibitors. *The effect of oral contraceptives on prolactin concentrations is controversial.
021
Reposted by @pituitarysociety.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 11/05/2026
#Acromegaly remains a challenging endocrine disorder to recognise in clinical practice, and screening all patients with clinical suspicion or associated comorbidities would shorten the delay in diagnosis www.thelancet.com/journals/lan... #pituitary #MedSky #EndoSky
011
Reposted by @pituitarysociety.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 02/05/2026
Sporadic #prolactinomas are the most common functioning #pituitary #adenomas, with a female predominance during reproductive years. In men, these adenomas are usually larger and more aggressive www.thelancet.com/journals/lan... #hyperprolactinaemia #MedSky #EndoSky #OncSky
001
Reposted by @pituitarysociety.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 06/03/2026
Prolactinomas are the most prevalent functional pituitary adenomas and can result in a proliferative endocrine disorder that is typically highly responsive to medical therapy www.thelancet.com/journals/lan... #prolactinomas #hyperprolactinaemia #pituitary #adenomas #MedSky #EndoSky #OncSky
001
Reposted by @pituitarysociety.bsky.social
Endocrine Society Journals @endosocjournals.bsky.social · 28/01/2026
Clomiphene Citrate in Men With Hypogonadism—Do we Need to Monitor IGF-1 in All Patients?. Read more in #JES: bit.ly/4pU09UK #SERMs #IGF-1 #ClomipheneCitrate @endocrinesociety.bsky.social
bit.ly
Clomiphene Citrate in Men With Hypogonadism—Do we Need to Monitor IGF-1 in All Patients?
Selective estrogen receptor modulators (SERMs) emerged as a plausible option for acromegaly treatment due to their estrogen-like effect of reducing insulin
001
Reposted by @pituitarysociety.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 27/01/2026
Health-care providers should consider #Addison's disease as a differential in a wide variety of presentations, and understand the correct interpretation and limitations of widely available cortisol assays thelancet.com/journals/lan... #adrenal insufficiency #adrenal crisis #MedSky #EndoSky
thelancet.com
Clinical features, investigation, and management of Addison's disease
Addison's disease is the manifestation of adrenal glucocorticoid and mineralocorticoid deficiency from T-cell mediated destruction of the adrenal cortex, and is the commonest cause of primary adrenal ...
021
Reposted by @pituitarysociety.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 25/01/2026
Despite oral corticosteroid replacement therapy, people with #Addison's disease have increased mortality in addition to reduced HRQoL and working ability thelancet.com/journals/lan... #adrenal insufficiency #adrenal crisis
031
pituitarysociety.bsky.social @pituitarysociety.bsky.social · 08/10/2025
Free Webinar November 10th ! Register for a discussion of all new and ' cool' in the pituitary arena, clinical and research, new medications in development, new guidelines. Large multidisciplinary international panel led by @mariafleseriu.bsky.social &ShlomoMelmed events.zoom.us/ev/AkPglLvFf...
events.zoom.us
Pituitary Advances in the Spotlight: 2025 Rapid-Fire Webinar
100
Reposted by @pituitarysociety.bsky.social
European Society of Endocrinology @esendocrinology.bsky.social · 12/08/2025
Delighted to share Commentary from #Pituitary, the official journal of @pituitarysociety.bsky.social who endorse the newly Revised ESE Guideline👉 ow.ly/JUOc50WCJTJ @geraldraverot.bsky.social
022
Reposted by @pituitarysociety.bsky.social
Maria Fleseriu, MD @mariafleseriu.bsky.social · 24/06/2025
Happy to share our recent #consensus #guideline on how to multidisciplinary manage #pituitary #incidentalomas; good news on data to recommend less frequent #imaging for many microadenomas , but also smaller macroadenomas. @pituitarysociety.bsky.social @ohsubrain.bsky.social @ohsunews.bsky.social
0113
Reposted by @pituitarysociety.bsky.social
Niki Karavitaki @karavitakin.bsky.social · 03/03/2025
Thromboprophylaxis in patients with endogenous Cushing's remains a hot topic. Our just released Position Statement is available at DOI: 10.1093/ejendo/lvaf017
011